The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Abstract
The delicate visual axis that makes precise vision possible is highly vulnerable to the destructive potential of immunogenic inflammation. Immune privilege of the eye is the experimental expression of the way in which evolution has coped with the countermanding threats to vision of ocular infections and ocular immunity and inflammation. Ocular immune privilege has five primary features that account for its existence: blood:ocular barriers, absent lymphatic drainage pathways, soluble immunomodulatory factors in aqueous humor, immunomodulatory ligands on the surface of ocular parenchymal cells, and indigenous, tolerance-promoting antigen-presenting cells (APCs). Three manifestations of ocular immune privilege that have received the most extensive study are the intraocular microenvironment, which is selectively anti-inflammatory and immunosuppressive; the prolonged acceptance of solid tissue and tumor allografts in the anterior chamber; and the induction of systemic tolerance to eye-derived antigens. Anterior chamber-associated immune deviation is known to arise when indigenous, ocular APCs capture eye-derived antigens and deliver them to the spleen where multicellular clusters of these cells, natural killer T cells, marginal zone B cells, and γδ T cells create an antigen-presentation environment that leads to CD4+ and CD8+ α/β T cells, which as regulators, suppress induction and expression of T helper cell type 1 (Th1) and Th2 immune expression systems. The ways the eye influences local and systemic immune responses to ocular antigens and pathogens carry risks to and benefits for mammalian organisms. As loss of sight is a powerful, negative-selecting force, the benefits of ocular immune privilege outweigh the risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Medawar, P. B. (1948) · PubMed · Cited by 1,109
The functions of thrombospondin-1 and-2
Lawler, J. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00143-5 · Cited by 440
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367
Sonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Streilein, J. W. (1995) · Science · doi:10.1126/science.270.5239.1158 · Cited by 295
Self-citationImmune Privilege and Immune Regulation in the Eye
Niederkorn, J. Y. (1990) · Advances in Immunology · doi:10.1016/s0065-2776(08)60755-5 · Cited by 262
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen.
Streilein, J. W., & Niederkorn, J. Y. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.5.1058 · Cited by 256
Self-citationWilbanks, G. A., Mammolenti, M., & Streilein, J. W. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220125 · Cited by 249
Self-citationSonoda, K.-H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S., & Stein-Streilein, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.42 · Cited by 240
Cited by
TFOS DEWS II pathophysiology report
Bron, A. J., de Paiva, C. S., Chauhan, S. K., Bonini, S., Gabison, E. E., Jain, S., Knop, E., Markoulli, M., Ogawa, Y., Perez, V., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.011 · Cited by 1,815
Comparative Aspects of Animal Regeneration
Brockes, J. P., & Kumar, A. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175336 · Cited by 490
A look at autoimmunity and inflammation in the eye
Caspi, R. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42440 · Cited by 482
Spaide, R. F., Gemmy Cheung, C. M., Matsumoto, H., Kishi, S., Boon, C. J. F., van Dijk, E. H. C., Mauget-Faysse, M., Behar-Cohen, F., Hartnett, M. E., Sivaprasad, S., et al. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100973 · Cited by 372
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S. P., & Murfee, W. L. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c180015 · Cited by 341
Gronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
Uveitis: A Potentially Blinding Disease
Durrani, O. M., Meads, C. A., & Murray, P. I. (2004) · Ophthalmologica · doi:10.1159/000078612 · Cited by 304
Hos, D., Matthaei, M., Bock, F., Maruyama, K., Notara, M., Clahsen, T., Hou, Y., Le, V. N. H., Salabarria, A.-C., Horstmann, J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.001 · Cited by 303
Biodegradable Implants for Sustained Drug Release in the Eye
Lee, S. S., Hughes, P., Ross, A. D., & Robinson, M. R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0159-x · Cited by 289
Zhou, R., & Caspi, R. R. (2010) · F1000 Biology Reports · doi:10.3410/b2-3 · Cited by 259
Taylor, A. W. (2009) · Eye · doi:10.1038/eye.2008.382 · Cited by 253
(2008) · PubMed Central · Cited by 183
Mechanisms of leukocyte migration across the blood-retina barrier
Crane, I. J., & Liversidge, J. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0106-7 · Cited by 152
Nanoparticle-based technologies for retinal gene therapy
Adijanto, J., & Naash, M. I. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.028 · Cited by 107
Timmers, A. M., Newmark, J. A., Turunen, H. T., Farivar, T., Liu, J., Song, C., Ye, G.-J., Pennock, S., Gaskin, C., Knop, D. R., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.144 · Cited by 77
Boyd, R. F., Boye, S. L., Conlon, T. J., Erger, K. E., Sledge, D. G., Langohr, I. M., Hauswirth, W. W., Komáromy, A. M., Boye, S. E., Petersen-Jones, S. M., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.31 · Cited by 37
VIGNAL-CLERMONT, C., YU-WAI-MAN, P., NEWMAN, N. J., CARELLI, V., MOSTER, M. L., BIOUSSE, V., SUBRAMANIAN, P. S., WANG, A.-G., DONAHUE, S. P., LEROY, B. P., et al. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.11.026 · Cited by 25
Metadata
- Authors
- Streilein, J. W.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-03
- Volume
- 74
- Issue
- 2
- Pages
- 179-185
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2132541143
- Cited by
- 367
- References
- 62
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.